Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of flupirtine versus placebo and tolterodine in incontinent overactive bladder
2006-004854-26Phase 2Terminated
- Sponsor
- elbion
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flupirtine and tolterodine in overactive bladder (OAB) (4 arms), sponsored by elbion. Started Dec 2006; status: terminated.
02
Drugs
flupirtinetolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2006-004854-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004854-26.